Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Mil Med Res. 2021 Nov 24;8(1):60. doi: 10.1186/s40779-021-00354-z.
The burden of kidney, bladder, and prostate cancers has changed in recent decades. This study aims to investigate the global and regional burden of, and attributable risk factors for genitourinary cancers during the past 30 years.
We extracted data of kidney, bladder, and prostate cancers from the Global Burden of Disease 2019 database, including incidence, mortality, disability-adjusted life-years (DALYs), and attributable risk factors from 1990 to 2019. Estimated annual percentage changes (EAPC) were calculated to assess the changes in age-standardized incidence rate, age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR). The associations between cancers burden and socio-demographic index (SDI) were also analyzed.
Compared with 1990, the global incident cases in 2019 were higher by 154.78%, 123.34%, and 169.11% for kidney, bladder, and prostate cancers, respectively. During the 30-year study period, there was a downward trend in ASMR and ASDR for bladder cancer (EAPC = - 0.68 and - 0.83, respectively) and prostate cancer (EAPC = - 0.75 and - 0.71, respectively), but an upward trend for kidney cancer (EAPC = 0.35 and 0.12, respectively). Regions and countries with higher SDI had higher incidence, mortality, and DALYs for all three types of cancers. The burden of bladder and prostate cancers was mainly distributed among older men, whereas the burden of kidney cancer increased among middle-aged men. Smoking related mortality and DALYs decreased, but high body mass index (BMI) and high fasting plasma glucose (FPG) related mortality and DALYs increased among kidney, bladder, and prostate cancers during the study period.
Kidney, bladder, and prostate cancers remain major global public health challenges, but with distinct trend for different disease entity across different regions and socioeconomic status. More proactive intervention strategies, at both the administrative and academic levels, based on the dynamic changes, are needed.
近几十年来,肾脏、膀胱和前列腺癌的负担发生了变化。本研究旨在探讨过去 30 年全球和各区域泌尿生殖系统癌症的负担和归因风险因素。
我们从 2019 年全球疾病负担数据库中提取了肾脏、膀胱和前列腺癌的数据,包括 1990 年至 2019 年的发病率、死亡率、残疾调整生命年(DALYs)和归因风险因素。计算了估计年变化百分比(EAPC),以评估年龄标准化发病率、年龄标准化死亡率(ASMR)和年龄标准化 DALYs 率(ASDR)的变化。还分析了癌症负担与社会人口指数(SDI)之间的关系。
与 1990 年相比,2019 年全球肾脏、膀胱和前列腺癌的发病例数分别增加了 154.78%、123.34%和 169.11%。在 30 年的研究期间,膀胱癌(EAPC=-0.68 和-0.83)和前列腺癌(EAPC=-0.75 和-0.71)的 ASMR 和 ASDR 呈下降趋势,而肾癌(EAPC=0.35 和 0.12)呈上升趋势。SDI 较高的地区和国家所有三种癌症的发病率、死亡率和 DALYs 都较高。膀胱癌和前列腺癌的负担主要分布在老年男性中,而肾癌的负担则在中年男性中增加。在研究期间,与吸烟相关的死亡率和 DALYs 下降,但与高体重指数(BMI)和高空腹血糖(FPG)相关的死亡率和 DALYs 增加。
肾脏、膀胱和前列腺癌仍然是全球主要的公共卫生挑战,但在不同地区和社会经济地位下,不同疾病实体的趋势不同。需要在行政和学术层面上,根据动态变化,采取更积极的干预策略。